Latest news
Prostate Cancer Treatment Is Creating a Metabolic Bill
A large JAMA Oncology study found metabolic abnormalities were frequently documented within the first year after men started ADT plus androgen receptor pathway inhibitor therapy. The survival gains are real. So is the cardiometabolic debt.
Breastfeeding Enters the MOGAD Conversation
Hodgkin Lymphoma Survivors Are Still Paying for Cure
Sanfilippo’s Approval Path Is Being Built Before Approval
Pertussis Rose. The Definition Amplified It.
More than half had silent atherosclerosis. Standard risk scores missed many of them
AstraZeneca’s Wainua lowered a disease-causing protein but did not reduce heart complications in a major trial
IPM Brief – Issue 26 | Science Has Left Home. Policy Hasn’t
FDA Is Asking the Right AI Question: Who Watches the Model After Approval?
Parkinson’s Gets a Cleaner Dopamine Bet
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.